Supernus Pharmaceuticals Inc (SUPN)
Edgewise Therapeutics Inc (EWTX)
Canopy Growth Corp (CGC)
10X Genomics Inc (TXG)
Tango Therapeutics Inc. (TNGX)
Mind Technology Inc (MIND)
MIND Technology Announces Fiscal 2026 Second Quarter Earnings Release and Conference Call Schedule
10X Genomics Inc (TXG)
Evofem Biosciences, Inc. (EVFM)
New Form 8-K - Evofem Biosciences, Inc. Filed: 2025-08-26 AccNo: 0001641172-25-025530 Size: 872 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits
10X Genomics Inc (TXG)
NovaBay Pharmaceuticals Inc. (NBY)
Premier Inc (PINC)
Waters Corporation (WAT)
Waters - Waters Corporation to Present at the Wells Fargo Healthcare Conference
Ginkgo Bioworks Holdings Inc. (DNA)
Lifestance Health Group Inc (LFST)
LifeStance to Present at the 23rd Annual Morgan Stanley Healthcare Conference